Opill, the first oral contraceptive approved by the US Food and Drug Administration for over-the-counter use, has arrived at most stores in certain retail pharmacy chains such as CVS, Walgreens and Walmart.
Opill has a suggested retail price of $19.99 for a one-month supply and $49.99 for a three-month supply, and at Opill.com, a six-month supply will be available for $89.99.
The George Washington University has experts available to discuss Opill and this new access. If you would like to schedule an interview, please contact Katelyn Deckelbaum, [email protected].
Julia Strasser, is the executive director of the Jacobs Institute of Women's Health and an assistant research professor of health policy and management at the GW Milken Institute School of Public Health. She is an expert on reproductive health care and access to essential care including abortion.
Sara Rosenbaum, is the Emeritus Professor of Health Policy and Management, and previously served as founding Chair of the Milken Institute School of Public Health Department of Health Policy at GW.
Caitlin Murphy is a research scientist in the Department of Health Policy and Management at the GW Milken Institute School of Public Health. She is an expert in maternal and child health, women’s health, reproductive health and disparities in health among vulnerable populations.
Linda Cassar, clinical associate professor at the GW School of Nursing, has worked primarily with the maternal/child health patient population over her 30 years as a nurse, working in labor and delivery, mother/baby, high-risk antepartum, and outpatient community perinatal education.
-GW-